Brief: Ipsen, Irlab Enter Exclusive Worldwide Licensing Agreement To Improve Lives Of People Living With Parkinson’s Disease

IRLAB Therapeutics AB

15/07/2021 18:46

July 15 (Reuters) - Ipsen SA  IPN.PA :
    * IPSEN AND IRLAB ENTER EXCLUSIVE WORLDWIDE LICENSING
AGREEMENT
AIMED TO IMPROVE THE LIVES OF PEOPLE LIVING WITH PARKINSON’S
DISEASE

Source text for Eikon:  ID:nBw8026mDa 
Further company coverage:  IPN.PA 

 ((Reuters.Briefs@thomsonreuters.com;))